Tufts CSDD Study -'Assessing the Financial Impact of Translational Pharmaceutics - A Platform for Accelerating Drug Development'
Learn how results from a recent Tufts CSDD study indicate that Translational Pharmaceutics® reduces development times by >12 months and lower R&D costs by >$100 million per approved new drug.
Published
No comments yet.